Breast cancer risk in metabolically healthy but overweight postmenopausal women

Cancer Research

Volumn 75, Issue 2, 2015, Pages 270-274

  Gunter, Marc J ^a   Xie, Xianhong ^b   Xue, Xiaonan ^b   Kabat, Geoffrey C ^b   Rohan, Thomas E ^b   Wassertheil Smoller, Sylvia ^b   Ho, Gloria Y F ^b   Wylie Rosett, Judith ^b   Greco, Theresa ^c   Yu, Herbert ^d   Beasley, Jeannette ^b   Strickler, Howard D ^b  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c STANFORD UNIVERSITY   (United States)

^d UNIVERSITY OF HAWAII CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; ESTROGEN; GESTAGEN; GLUCOSE BLOOD LEVEL; INSULIN;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; ASIAN; BLACK PERSON; BREAST CANCER; CALORIC INTAKE; CANCER RISK; CAUCASIAN; COHORT ANALYSIS; CONTROLLED STUDY; ETHNICITY; FEMALE; GLYCEMIC INDEX; HEALTH STATUS; HISPANIC; HORMONAL THERAPY; HUMAN; INSULIN METABOLISM; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MENARCHE; METABOLIC EQUIVALENT; OBESITY; OBSERVATIONAL STUDY; PHYSICAL ACTIVITY; POSTMENOPAUSE; PROSPECTIVE STUDY; WOMEN'S HEALTH; AGE; BLOOD; BREAST NEOPLASMS; GLUCOSE BLOOD LEVEL; METABOLISM; MIDDLE AGED; MULTIVARIATE ANALYSIS; OVERWEIGHT; PROPORTIONAL HAZARDS MODEL; RISK; UNITED STATES;

AGE FACTORS; AGED; BLOOD GLUCOSE; BREAST NEOPLASMS; FEMALE; HUMANS; INSULIN; INSULIN RESISTANCE; MIDDLE AGED; MULTIVARIATE ANALYSIS; OVERWEIGHT; POSTMENOPAUSE; PROPORTIONAL HAZARDS MODELS; RISK; UNITED STATES;

EID: 84920971232     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-14-2317     Document Type: Article

References (22)

1. Lahmann PH, Hoffmann K, Allen N, van Gils CH, Khaw KT, Tehard B, et al. Body size and breast cancer risk: findings from the European Prospective Investigation into Cancer and Nutrition (EPIC). Int J Cancer 2004;111: 762-71.
2. van den Brandt PA, Spiegelman D, Yaun SS, Adami HO, Beeson L, Folsom AR, et al. Pooled analysis of prospective cohort studies on height, weight, and breast cancer risk. Am J Epidemiol 2000;152:514-27.
3. Key T, Appleby P, Barnes I, Reeves G. Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies. J Natl Cancer Inst 2002;94:606-16.
4. Key TJ, Appleby PN, Reeves GK, Roddam A, Dorgan JF, Longcope C, et al. Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women. J Natl Cancer Inst 2003;95:1218-26.
5. Ish-Shalom D, Christoffersen CT, Vorwerk P, Sacerdoti-Sierra N, Shymko RM, Naor D, et al. Mitogenic properties of insulin and insulin analogues mediated by the insulin receptor. Diabetologia 1997;40:S25-31.
6. Chappell J, Leitner JW, Solomon S, Golovchenko I, Goalstone ML, Draznin B. Effect of insulin on cell cycle progression in MCF-7 breast cancer cells. Direct and potentiating in fl uence. J Biol Chem 2001;276: 38023-8.
7. Gunter MJ, Hoover DR, Yu H, Wassertheil-Smoller S, Rohan TE, Manson JE, et al. Insulin, insulin-like growth factor-I, and risk of breast cancer in postmenopausal women. J Natl Cancer Inst 2009;101: 48-60.
8. Kabat GC, Kim M, Caan BJ, Chlebowski RT, Gunter MJ, Ho GY, et al. Repeated measures of serum glucose and insulin in relation to postmenopausal breast cancer. Int J Cancer 2009;125:2704-10.
9. Hvidtfeldt UA, Gunter MJ, Lange T, Chlebowski RT, Lane D, Farhat GN, et al. Quantifying mediating effects of endogenous estrogen and insulin in the relation between obesity, alcohol consumption, and breast cancer. Cancer Epidemiol Biomarkers Prev 2012;21: 1203-12.
10. Durward CM, Hartman TJ,Nickols-Richardson SM. All-cause mortality risk of metabolically healthy obese individuals in NHANES III. J Obes 2012; 2012:460321.
11. Stefan N, Kantartzis K, Machann J, Schick F, Thamer C, Rittig K, et al. Identification and characterization of metabolically benign obesity in humans. Arch Intern Med 2008;168:1609-16.
12. Wildman RP, Muntner P, Reynolds K, McGinn AP, Rajpathak S, Wylie-Rosett J, et al. The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999 - 2004). Arch Intern Med 2008;168: 1617-24.
13. Ogorodnikova AD, Kim M, McGinn AP, Muntner P, Khan U, Wildman RP. Incident cardiovascular disease events in metabolically benign obese individuals. Obesity 2012;20:651-9.
14. Hosseinpanah F, Barzin M, Sheikholeslami F, Azizi F. Effect of different obesity phenotypes on cardiovascular events in Tehran Lipid and Glucose Study (TLGS). Am J Cardiol 2011;107:412-6.
15. St-Pierre AC, Cantin B, Mauriege P, Bergeron J, Dagenais GR, Despres JP, et al. Insulin resistance syndrome, body mass index and the risk of ischemic heart disease. CMAJ 2005;172:1301-5.
16. Voulgari C, Tentolouris N, Dilaveris P, Tousoulis D, Katsilambros N, Stefanadis C. Increased heart failure risk in normal-weight people with metabolic syndrome compared with metabolically healthy obese individuals. J Am Coll Cardiol 2011;58:1343-50.
17. Group TWsHIS. Design of the Women's Health Initiative clinical trial and observational study. Control Clin Trials 1998;19:61-109.
18. Ligibel JA, Strickler HD. Obesity and its impact on breast cancer. Am Soc Clin Oncol Educ Book 2013;2013:52-9.
19. Prentice RL. A case-cohort design for epidemiologic studies and disease prevention trials. Biometrika 1986;73:1-11.
20. VerheusM, Peeters PH, Rinaldi S, Dossus L, Biessy C, Olsen A, et al. Serum C-peptide levels and breast cancer risk: results from the European Prospective Investigation into Cancer and Nutrition (EPIC). Int J Cancer 2006;119:659-67.
21. Keinan-Boker L, Bueno De Mesquita HB, Kaaks R, Van Gils CH, Van Noord PA, Rinaldi S, et al. Circulating levels of insulin-like growth factor I, its binding proteins -1,-2, -3, C-peptide and risk of postmenopausal breast cancer. Int J Cancer 2003;106:90-5.
22. Toniolo P, Bruning PF, Akhmedkhanov A, Bonfrer JM, Koenig KL Lukanova A, et al. Serum insulin-like growth factor-I and breast cancer. Int J Cancer 2000;88:828-32.